These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31519154)

  • 1. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.
    Slaughter JL; Cua CL; Notestine JL; Rivera BK; Marzec L; Hade EM; Maitre NL; Klebanoff MA; Ilgenfritz M; Le VT; Lewandowski DJ; Backes CH
    BMC Pediatr; 2019 Sep; 19(1):333. PubMed ID: 31519154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
    Dani C; Bertini G; Corsini I; Elia S; Vangi V; Pratesi S; Rubaltelli FF
    Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan.
    Hundscheid T; Donders R; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Nuytemans DHGM; van Overmeire B; Mulder AL; de Boode WP;
    Trials; 2021 Sep; 22(1):627. PubMed ID: 34526095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
    Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural evolution of patent ductus arteriosus in the extremely preterm infant.
    Rolland A; Shankar-Aguilera S; Diomandé D; Zupan-Simunek V; Boileau P
    Arch Dis Child Fetal Neonatal Ed; 2015 Jan; 100(1):F55-8. PubMed ID: 25169243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
    Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
    BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
    Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
    BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
    Grass B; Baumann P; Arlettaz R; Fouzas S; Meyer P; Spanaus K; Wellmann S
    Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment.
    Martinovici D; Vanden Eijnden S; Unger P; Najem B; Gulbis B; Maréchal Y
    Pediatr Cardiol; 2011 Oct; 32(7):953-7. PubMed ID: 21656237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
    Ohlsson A; Shah PS
    Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Conservative Approach for Persistent Patent Ductus Arteriosus in Preterm Infants: Neurodevelopmental Outcomes at 5 Years of Age.
    Kaga M; Sanjo M; Sato T; Miura Y; Ono T
    Tohoku J Exp Med; 2019 Nov; 249(3):155-161. PubMed ID: 31708567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.
    Kluckow M; Evans N
    J Pediatr; 1995 Nov; 127(5):774-9. PubMed ID: 7472835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective factors against preterm infants to develop significant patent ductus arteriosus.
    Huang HW; Lin C; Hsu KH; Hsu SY; Mok TY; Wu IH; Lai MY; Lien R
    Pediatr Neonatol; 2021 Jul; 62(4):379-386. PubMed ID: 33931344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.